✦ LIBER ✦

Low-dose bacille Calmette-Guerin (BCG) therapy in superficial high-risk bladder cancer: a phase II study with the BCG strain Connaught Canada

✍ Scribed by D. Mack; J. Frick

Book ID: 115197875
Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 275 KB
Volume: 75
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.1995.tb07308.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five-year results of a phase ii study wi

Five-year results of a phase ii study with low-dose bacille calmette-guérin therapy in high-risk superficial bladder cancer

✍ D. Mack; J. Frick 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 401 KB

1786 A PROSPECTIVE COMPARATIVE STUDY OF

1786 A PROSPECTIVE COMPARATIVE STUDY OF INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG) THERAPY WITH THE TOKYO OR CONNAUGHT STRAINS FOR NON-MUSCLE INVASIVE BLADDER CANCER

✍ Sengiku, Atsushi; Ito, Masaaki; Miyazaki, Yu; Sawazaki, Harutake; Takahashi, Tak 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 53 KB

655 LONG-TERM FOLLOW UP OF THE EFFECTIVE

655 LONG-TERM FOLLOW UP OF THE EFFECTIVENESS OF STANDARD DOSE BCG (81 MG. CONNAUGHT STRAIN) COMPARING WITH A THREE FOLD REDUCE DOSE (27 MG.) IN HIGH RISK NON MUSCLE INVASIVE BLADDER CANCER. CUETO GROUP

✍ M. Unda; R. Madero; E. Solsona; Gomez J.M. Fernandez; Piñeiro L. Martinez; A. Oj 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 503 KB

491 Evaluation of urine interleukin-2 (I

491 Evaluation of urine interleukin-2 (IL2), IL6 and IL10 levels during intravesical therapy with interferon α-2B (IFNα-2B) alone and IFINα-2B combined with low dose bacillus Calmette-Guérin (BCG) in superficial bladder cancer

✍ L. Özdal; T. Özdemir; K. Yakupoǧlu; S. Bulut; A. Memiş; O. Sariyüce 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 207 KB